Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Advances in Therapy
Published in: Advances in Therapy 10/2016

Open Access 01-10-2016 | Review

Systematic Review of Current Devices for 24-h Intraocular Pressure Monitoring

Authors: Sabita M. Ittoop, Jeffrey R. SooHoo, Leonard K. Seibold, Kaweh Mansouri, Malik Y. Kahook

Published in: Advances in Therapy | Issue 10/2016

Login to get access

Abstract

Glaucoma is a common optic neuropathy that can lead to irreversible vision loss, and intraocular pressure (IOP) is the only known modifiable risk factor. The primary method of treating glaucoma involves lowering IOP using medications, laser and/or invasive surgery. Currently, we rely on in-office measurements of IOP to assess diurnal variation and to define successful management of disease. These measurements only convey a fraction of a patient’s circadian IOP pattern and may frequently miss peak IOP levels. There is an unmet need for a reliable and accurate device for 24-h IOP monitoring. The 24-h IOP monitoring devices that are currently available and in development fall into three main categories: self-monitoring, temporary continuous monitoring, and permanent continuous monitoring. This article is a systematic review of current and future technologies for measuring IOP over a 24-h period.
Literature
1.
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014:121;2081–90.
2.
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–7.
3.
Sit AJ. Continuous monitoring of intraocular pressure: rationale and progress toward a clinical device. J Glaucoma. 2009;18(4):272–9.CrossRefPubMed
4.
Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Investig Ophthalmol Vis Sci. 2000;41(9):2566–73.
5.
Hughes E, Spry P, Diamond J. 24-hour monitoring of intraocular pressure in glaucoma management: a retrospective review. J Glaucoma. 2003;12(3):232–6.
6.
Barkana Y, Anis S, Liebmann J, Tello C, Ritch R. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol. 2006;124(6):793–7.CrossRefPubMed
7.
Konstas AG, Mantziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 2008;115(2):182–5.
8.
Liu JHK, Weinreb RN. Monitoring intraocular pressure for 24 h. Br J Ophthalmol. 2011;95:599–600.
9.
Whitacre MM, Stein R. Sources of error with use of Goldmann-type tonometers. Surv Ophthalmol. 1993;38:1–30.
10.
Akram A, Yaqub A, Dar AJ, Fiaz. Pitfalls in intraocular pressure measurement by Goldmann-type applanation tonometers. Pak J Ophthalmol. 2009;25:22–4.
11.
12.
Hessemer V, Rössler R, Jacobi KW. Tono-Pen, a new tonometer. Int Ophthalmol. 1989;13:51–6.
13.
Kao SF, Lichter PR, Bergstrom TJ, Rowe S, Musch DC. Clinical comparison of the Oculab Tono-Pen to the Goldmann applanation tonometer. Ophthalmology. 1987;94(12):1541–4.
14.
Liang SYW, Lee GA, Shields D. Self-tonometry in glaucoma management-past, present and future. Surv Ophthalmol. 2009:54;450–62.
15.
Judge AJ, Najafi K, Lee DA, Miller KM. Corneal endothelial toxicity of topical anesthesia. Ophthalmology. 1997;104(9):1373–9.CrossRefPubMed
16.
De Smedt S. Noninvasive intraocular pressure monitoring: current insights. Clin Ophthalmol. 2015;9:1385–92.
17.
Rietveld E, van den Bremer DA, Völker-Dieben HJ. Clinical evaluation of the pressure phosphene tonometer in patients with glaucoma. Br J Ophthalmol. 2005;89(5):537–9.
18.
Li J, Herndon LW, Asrani SG, Stinnett S, Allingham RR. Clinical comparison of the Proview eye pressure monitor with the Goldmann applanation tonometer and the Tonopen. Arch Ophthalmol. 2004;122(8):1117–21.
19.
20.
Cervino A. Rebound tonometry: new opportunities and limitations of non-invasive determination of intraocular pressure. Br J Ophthalmol. 2006;90(12):1444–6.CrossRefPubMedPubMedCentral
21.
22.
Iliev ME, Goldblum D, Katsoulis K, Amstutz C, Frueh B. Comparison of rebound tonometry with Goldmann applanation tonometry and correlation with central corneal thickness. Br J Ophthalmol. 2006;90(7):833–5.
23.
Salim S, Du HWJ. Comparison of intraocular pressure measurements and assessment of intraobserver and interobserver reproducibility with the portable ICare rebound tonometer and Goldmann applanation tonometer in glaucoma patients. J Glaucoma. 2013;22(4):325–9.CrossRefPubMed
24.
Brusini P, Salvetat ML, Zeppieri M, Tosoni C, Parisi L. Comparison of ICare tonometer with Goldmann applanation tonometer in glaucoma patients. J Glaucoma. 2006;15(3):213–7.CrossRefPubMed
25.
Shin J, Lee JW, Kim EA, Caprioli J. The effect of corneal biomechanical properties on rebound tonometer in patients with normal-tension glaucoma. Am J Ophthalmol. 2015;159(1):144–54.CrossRefPubMed
26.
Jorge JMM, González-Méijome JM, Queirós A, Fernandes P, Parafita MA. Correlations between corneal biomechanical properties measured with the ocular response analyzer and ICare rebound tonometry. J Glaucoma. 2008;17(6):442–8.
27.
González-Méijome JM, Jorge J, Queirós A, et al. Age differences in central and peripheral intraocular pressure using a rebound tonometer. Br J Ophthalmol. 2006;90(12):1495–500.CrossRefPubMedPubMedCentral
28.
Muttuvelu DV, Baggesen K, Ehlers N. Precision and accuracy of the ICare tonometer—peripheral and central IOP measurements by rebound tonometry. Acta Ophthalmol. 2012;90(4):322–6.CrossRefPubMed
29.
Jóhannesson G, Hallberg P, Eklund A, Lindén C. Pascal, ICare and Goldmann applanation tonometry–a comparative study. Acta Ophthalmol. 2008;86(6):614–21.
30.
Rosentreter A, Jablonski KS, Mellein AC, Gaki S, Hueber A, Dietlein TS. A new rebound tonometer for home monitoring of intraocular pressure. Graefe’s Arch Clin Exp Ophthalmol. 2011;249(11):1713–9.CrossRef
31.
Kim KN, Jeoung JW, Park KH, Yang MK, Kim DM. Comparison of the new rebound tonometer with Goldmann applanation tonometer in a clinical setting. Acta Ophthalmol. 2013;91(5):e392–6.
32.
Sakamoto M, Kanamori A, Fujihara M, Yamada Y, Nakamura M, Negi A. Assessment of IcareONE rebound tonometer for self-measuring intraocular pressure. Acta Ophthalmol. 2014;92(3):243–8.CrossRefPubMed
33.
Halkiadakis I, Stratos A, Stergiopoulos G, et al. Evaluation of the Icare-ONE rebound tonometer as a self-measuring intraocular pressure device in normal subjects. Graefes Arch Clin Exp Ophthalmol. 2012;250(8):1207–11.CrossRefPubMed
34.
Moreno-Montañés J, Martínez-de-la-Casa JM, Sabater AL, Morales-Fernandez L, Sáenz C, Garcia-Feijoo J. Clinical evaluation of the new rebound tonometers Icare PRO and Icare ONE compared with the Goldmann tonometer. J Glaucoma. 2015;24(7):527–32. doi:10.​1097/​IJG.​0000000000000058​.
35.
36.
Greene M, Gilman B. Intraocular pressure measurement with instrumented contact lenses. Invest Ophthalmol Vis Sci. 1974;13(4):299–302.
37.
Mansouri K. The road ahead to continuous 24-hour intraocular pressure monitoring in glaucoma. J Ophthalmic Vis Res. 2014;9(2):260–8.PubMedPubMedCentral
38.
39.
Twa MD, Roberts CJ, Karol HJ, Mahmoud AM, Weber PA, Small RH. Evaluation of a contact lens-embedded sensor for intraocular pressure measurement. J Glaucoma. 2010;19(6):382–90.CrossRefPubMedPubMedCentral
40.
41.
42.
Mansouri K, Medeiros FA, Tafreshi A, Weinreb RN. Continuous 24-hour monitoring of intraocular pressure patterns with a contact lens sensor: safety, tolerability, and reproducibility in patients with glaucoma. Arch Ophthalmol. 2012;130(12):1534–9.CrossRef
43.
Leonardi M, Pitchon EM, Bertsch A, Renaud P, Mermoud A. Wireless contact lens sensor for intraocular pressure monitoring: assessment on enucleated pig eyes. Acta Ophthalmol. 2009;87(4):433–7.CrossRefPubMed
44.
Agnifili L, Mastropasqua R, Frezzotti P, et al. Circadian intraocular pressure patterns in healthy subjects, primary open angle and normal tension glaucoma patients with a contact lens sensor. Acta Ophthalmol. 2015;93(1):e14–21.CrossRefPubMed
45.
Tojo N, Hayashi A, Otsuka M, Miyakoshi A. Fluctuations of the intraocular pressure in pseudoexfoliation syndrome and normal eyes measured by a contact lens sensor. J Glaucoma. 2016;25(5):e463–8. doi:10.​1097/​IJG.​0000000000000292​.
46.
Parekh AS, Mansouri K, Weinreb RN, Tafreshi A, Korn BS, Kikkawa DO. Twenty-four-hour intraocular pressure patterns in patients with thyroid eye disease. Clin Exp Ophthalmol. 2015;43(2):108–14
47.
Lee JWY, Fu L, Chan JCH, Lai JSM. Twenty-four-hour intraocular pressure related changes following adjuvant selective laser trabeculoplasty for normal tension glaucoma. Medicine (Baltimore). 2014;93(27):e238.
48.
Tojo N, Oka M, Miyakoshi A, Ozaki H, Hayashi A. Comparison of fluctuations of intraocular pressure before and after selective laser trabeculoplasty in normal-tension glaucoma patients. J Glaucoma. 2013;23(8):138–43.
49.
Mansouri K, Medeiros F, Weinreb R. Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor. Clin Experiment Ophthalmol. 2015;43(9):787–95.CrossRefPubMed
50.
Holló G, Kóthy P, Vargha P. Evaluation of continuous 24-hour intraocular pressure monitoring for assessment of prostaglandin-induced pressure reduction in glaucoma. J Glaucoma. 2014;23(1):e6–12.
51.
De Moraes CG, Jasien JV, Simon-Zoula S, Liebmann JMRR. Visual field change and 24-hour IOP-related profile with a contact lens sensor in treated glaucoma patients. Ophthalmology. 2015;15:S0161–6420.
52.
Mansouri K, Weinreb RN. Meeting an unmet need in glaucoma: continuous 24-h monitoring of intraocular pressure. Expert Rev Med Dev. 2012;9:225–31.CrossRef
53.
Melki S, Todani A, Cherfan G. An implantable intraocular pressure transducer: initial safety outcomes. JAMA Ophthalmol. 2014;132(10):1221–5.
54.
55.
Todani A, Behlau I, Fava MA, et al. Intraocular pressure measurement by radio wave telemetry. Invest Ophthalmol Vis Sci. 2011;52(13):9573–80.
56.
Kim Y, Kim M, Park K, et al. Preliminary study on implantable inductive-type sensor for continuous monitoring of intraocular pressure. Clin Exp Ophthalmol. 2015;43(9):830–7.CrossRefPubMed
57.
Koutsonas A, Walter P, Roessler G, Plange N. Implantation of a novel telemetric intraocular pressure sensor in patients with glaucoma (ARGOS study): 1-year results. Invest Ophthalmol Vis Sci. 2015;56(2):1063–9.CrossRefPubMed
58.
59.
60.
61.
Varel Ç, Shih Y-C, Otis BP, Shen TS, Böhringer KF. A wireless intraocular pressure monitoring device with a solder-filled microchannel antenna. J Micromech Microeng. 2014;24(4):045012.
62.
63.
Chow EY, Chlebowski AL, Irazoqui PP. A miniature-implantable RF-wireless active glaucoma intraocular pressure monitor. IEEE Trans Biomed Circuits Syst 2010;4:340–9.
Metadata
Title
Systematic Review of Current Devices for 24-h Intraocular Pressure Monitoring
Authors
Sabita M. Ittoop
Jeffrey R. SooHoo
Leonard K. Seibold
Kaweh Mansouri
Malik Y. Kahook
Publication date
01-10-2016
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 10/2016
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-016-0388-4

Other articles of this Issue 10/2016

Advances in Therapy 10/2016 Go to the issue

Original Research

Pharmacokinetic Properties of Oral Lafutidine Tablets and the Effect of Food on its Pharmacokinetics in Healthy Chinese Subjects

Review

Self-Care in the Twenty First Century: A Vital Role for the Pharmacist

Brief Report

Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study

Brief Report

The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol

Original Research

Management and Outcome of Periprocedural Cardiac Perforation and Tamponade with Radiofrequency Catheter Ablation of Cardiac Arrhythmias: A Single Medium-Volume Center Experience

Original Research

Simple Predictive Model for Identifying Patients with Chronic Hepatitis C and Hepatitis C Virus Genotype 4 Infection with a High Probability of Sustained Virologic Response with Peginterferon Alfa-2a/Ribavirin: Pooled Analysis of Data from Two Large, International Cohort Studies

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits